Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Weich

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Oncotarget|June 4, 2016
The impact of 177Lu-octreotide therapy on 99mTc-MAG3 clearance is not predictive for late nephropathyRudolf A Werner, Seval Beykan, Takahiro Higuchi, et al.
Clinical Nuclear Medicine|November 10, 2022
Impact of 68 Ga-FAPI-04 PET/CT on Staging and Therapeutic Management in Patients With Digestive System TumorsAleksander Kosmala, Sebastian E Serfling, Wiebke Schlötelburg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 5, 2023
Molecular imaging of arterial fibroblast activation protein: association with calcified plaque burden and cardiovascular risk factorsAleksander Kosmala, Sebastian E Serfling, Kerstin Michalski, et al.
Clinical Nuclear Medicine|February 8, 2023
Somatostatin Receptor-Directed PET/CT for Therapeutic Decision-Making and Disease Control in Patients Affected With Small Cell Lung CancerSebastian E Serfling, Philipp E Hartrampf, Yingjun Zhi, et al.
Clinical Nuclear Medicine|May 11, 2023
Impact of CXCR4-Directed PET/CT on Staging and Proposed Oncologic Management in Patients With Digestive System TumorsAlexander Weich, Sebastian E Serfling, Wiebke Schlötelburg, et al.
Cancers|May 13, 2026
Impact of Neuroendocrine Neoplasm-Specific Systemic Treatments on Somatostatin Receptors Expression and Function in Neuroendocrine Tumor CellsChristof Däubler, Clara Böttcher, Laura-Sophie Landwehr, et al.
Theranostics|January 8, 2025
C-X-C motif chemokine receptor 4-directed PET signal in the arterial tree is not consistently linked to calcified plaque burden and cardiovascular riskAleksander Kosmala, Natalie Hasenauer, Sebastian E Serfling, et al.
Molecular Imaging and Biology|March 2, 2022
Training on Reporting and Data System (RADS) for Somatostatin-Receptor Targeted Molecular Imaging Can Reduce the Test Anxiety of Inexperienced ReadersAlexander Weich, Takahiro Higuchi, Ralph A Bundschuh, et al.
Frontiers in Surgery|May 26, 2022
Endoscopic Management of Large Leakages After Upper Gastrointestinal SurgeryStanislaus Reimer, Johan F Lock, Sven Flemming, et al.
Molecular Imaging and Biology|March 21, 2022
Impact of Tumor Burden on Normal Organ Distribution in Patients Imaged with CXCR4-Targeted [<sup>68</sup>Ga]Ga-PentixaFor PET/CTSebastian E Serfling, Constantin Lapa, Niklas Dreher, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Oncotarget|June 4, 2016
The impact of 177Lu-octreotide therapy on 99mTc-MAG3 clearance is not predictive for late nephropathyRudolf A Werner, Seval Beykan, Takahiro Higuchi, et al.
Clinical Nuclear Medicine|November 10, 2022
Impact of 68 Ga-FAPI-04 PET/CT on Staging and Therapeutic Management in Patients With Digestive System TumorsAleksander Kosmala, Sebastian E Serfling, Wiebke Schlötelburg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 5, 2023
Molecular imaging of arterial fibroblast activation protein: association with calcified plaque burden and cardiovascular risk factorsAleksander Kosmala, Sebastian E Serfling, Kerstin Michalski, et al.
Clinical Nuclear Medicine|February 8, 2023
Somatostatin Receptor-Directed PET/CT for Therapeutic Decision-Making and Disease Control in Patients Affected With Small Cell Lung CancerSebastian E Serfling, Philipp E Hartrampf, Yingjun Zhi, et al.
Clinical Nuclear Medicine|May 11, 2023
Impact of CXCR4-Directed PET/CT on Staging and Proposed Oncologic Management in Patients With Digestive System TumorsAlexander Weich, Sebastian E Serfling, Wiebke Schlötelburg, et al.
Cancers|May 13, 2026
Impact of Neuroendocrine Neoplasm-Specific Systemic Treatments on Somatostatin Receptors Expression and Function in Neuroendocrine Tumor CellsChristof Däubler, Clara Böttcher, Laura-Sophie Landwehr, et al.
Theranostics|January 8, 2025
C-X-C motif chemokine receptor 4-directed PET signal in the arterial tree is not consistently linked to calcified plaque burden and cardiovascular riskAleksander Kosmala, Natalie Hasenauer, Sebastian E Serfling, et al.
Molecular Imaging and Biology|March 2, 2022
Training on Reporting and Data System (RADS) for Somatostatin-Receptor Targeted Molecular Imaging Can Reduce the Test Anxiety of Inexperienced ReadersAlexander Weich, Takahiro Higuchi, Ralph A Bundschuh, et al.
Frontiers in Surgery|May 26, 2022
Endoscopic Management of Large Leakages After Upper Gastrointestinal SurgeryStanislaus Reimer, Johan F Lock, Sven Flemming, et al.
Molecular Imaging and Biology|March 21, 2022
Impact of Tumor Burden on Normal Organ Distribution in Patients Imaged with CXCR4-Targeted [<sup>68</sup>Ga]Ga-PentixaFor PET/CTSebastian E Serfling, Constantin Lapa, Niklas Dreher, et al.
Pageof 6